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Abstract
Although in vivo evidence indicates that salsolinol, the condensation product of acetaldehyde and dopamine, has properties
thatmaycontributetoalcoholabuse,theunderlyingmechanismshavenotbeenfullyelucidated.Wehavereportedpreviously
that salsolinol stimulates dopamine neurons in the posterior ventral tegmental area (p-VTA) partly by reducing inhibitory
GABAergictransmission,and thatethanol increasesglutamatergictransmissiontoVTA-dopamine neuronsviatheactivationof
dopamine D1 receptors (D1Rs). In this study, we tested the hypothesis that salsolinol stimulates dopamine neurons involving
activation of D1Rs. By using whole-cell recordings on p-VTA-dopamine neurons in acute brain slices of rats, we found that
salsolinol-induced increase in spike frequency of dopamine neurons was substantially attenuated by DL-2-amino-5-
phosphono-valeric acid and 6, 7-dinitroquinoxaline-2, 3-dione, the antagonists of glutamatergic N-Methyl-D-aspartic acid and
a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors. Moreover, salsolinol increased the amplitude of evoked
excitatory postsynaptic currents (EPSCs) and the frequency but not the amplitude of spontaneous EPSCs. Additionally,
SKF83566, a D1R antagonist attenuated the salsolinol-induced facilitation of EPSCs and of spontaneous firing of dopamine
neurons. Our data reveal that salsolinol enhances glutamatergic transmission onto dopamine neurons via activation of D1Rs at
the glutamatergic afferents in dopamine neurons, which contributes to salsolinol’s stimulating effect on p-VTA dopamine
neurons. This appears to be a novel mechanism which contributes toward rewarding properties of salsolinol.
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Introduction
The racemic mixture of salsolinol ((R) + (s)-salsolinol) is formed
by nonenzymatic Pictet-Spengler condensation of dopamine with
acetaldehyde, the major metabolite of ethanol in the brains of
mammals [1,2]. Salsolinol has been proposed to play a role in
the etiology of alcoholism [3], and to the rewarding properties of
ethanol [4]. Early animal studies revealed that salsolinol
promotes alcohol drinking [5,6]. More recent studies showed
that rats self-administer salsolinol into posterior VTA (p-VTA), a
key region in the brain reward system [7,8], and that
microinjection of salsolinol into the p-VTA of rats induces
conditioned place preference [9]. Furthermore, such behaviors
seem to depend on activation of dopaminergic (DA) neurons [8]
and associated with enhanced dopamine levels in the ipsilateral
nucleus accumbens shell [9]. With patch clamp techniques, we
recently showed that salsolinol (0.01–1 mM) dose-dependently
stimulates DA neurons in the p-VTA in acute midbrain slices of
rats. Salsolinol decreased GABAergic synaptic transmission onto
p-VTA DA neurons, and gabazine, an antagonist of GABAA
receptors substantially attenuated salsolinol-induced increase in
firing rate of DA neurons. This phenomenon suggests that
salsolinol stimulates DA neurons through a mechanism of
disinhibition [10]. Interestingly, gabazine (10 mM) failed to
completely abolish salsolinol-induced increase in DA neuron
firing, indicating that other mechanisms may also be involved.
In addition to potent inhibitory GABAergic afferents [11],
VTA DA neurons receive glutamatergic (Gluergic) inputs from
diverse brain nuclei [12,13] and from the Gluergic neurons in
the VTA [14]. These diverse sources of Gluergic afferents may
enable DA neurons to respond to a wide range of environmental
stimuli. Such excitatory Gluergic synaptic input is a key
component in the regulation of DA cell excitability [15,16] and
is known to play an important role in the actions of many drugs
of abuse [17,18] including ethanol [19]. Previous in vivo
evidence indicates that activation of dopamine D1 receptors
(D1Rs) can increase the release of glutamate in the VTA [20]. In
recent in vitro studies, we have demonstrated that acute ethanol
facilitates Gluergic transmission to VTA DA neurons via the
activation of D1Rs at Gluergic afferents [21,22]. This study was
set to test the hypothesis that salsolinol stimulates DA neurons
involving activation of D1Rs at Gluergic afferents.
Methods
Experimental procedures
All experiments were performed in accordance with the
guidelines of the National Institutes of Health Guide for the Care
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Institutional Animal Care and Use Committee of the University of
Medicine and Dentistry of New Jersey. All efforts were made to
minimize animal suffering and to reduce the number of animal
used. The experiments were performed on Sprague-Dawley rats
aged 15–25 (2061) postnatal (P) days.
Slice preparation
The midbrain slices were prepared as described previously
[23,24]. Animals were anesthetized and then killed by decapita-
tion. The brain was removed and a midbrain block (containing the
VTA) was isolated. It was glued to the cutting stage of a VF-200
slicer (Precisionary Instruments Inc., Greenville, NC, USA). While
the brain was kept in ice-cold glycerol-based artificial cerebrospi-
nal fluid (GACSF) – containing 252 mM glycerol, 1.6 mM KCl,
1.2 mM NaH2PO4, 1.2 mM MgCl2, 2.4 mM CaCl2,1 8 m M
NaHCO3, and 11 mM glucose, and oxygenated with 95% O2/5%
CO2. 200–250 mm thick slices were cut in the coronal plane. The
slices (two per animal) were allowed to recover for at least 1 h in a
holding chamber in regular artificial cerebrospinal fluid (ACSF),
which has the same composition as GACSF, except that glycerol
was replaced with 126 mM NaCl.
Electrophysiological recording in midbrain slices
Cells in midbrain slices were visualized with an upright
microscope (E600FN, Nikon, Tokyo, Japan) and near-infrared
illumination. Electrical signals were obtained in whole-cell patch
clamp technique with MultiClamp 700 A amplifiers (Molecular
Devices Co., Union City, CA, USA), a Digidata 1320 A A/D
converter (Molecular Devices Co.) and pCLAMP 9.2 software
(Molecular Devices Co.). Data were filtered at 2 kHz and sampled
at 5 kHz. The patch electrodes had a resistance of 4–6 MV when
filled with the pipette solution containing (in mM) 125 K
gluconate, 2.8 NaCl, 2 MgCl2, 0.6 EGTA, 10 HEPES, 2 ATP-
Na, and 0.3 GTP-Na for whole-cell current clamp recordings. For
whole-cell voltage clamp recordings the patch electrodes were
filled with a pipette solution containing (in mM): 135 K gluconate,
5 KCl, 2 MgCl2, 10 HEPES, 2 Mg ATP, 0.2 GTP, and 2 QX-
314. The pH was adjusted to 7.2 with Tris base and osmolarity to
300 mOsmol/L with sucrose. A single slice was transferred into a
0.4 ml recording chamber, where it was held down by a platinum
ring. Warm carbogenated ACSF flowed through the bath (1.5–
2.0 ml/min). All recordings were carried out at 32uC, maintained
by an automatic temperature controller (Warner Instruments,
Hamden, CT). For analyzing the changes in firing rate, we
adapted the method used by Brodie’s group [25]. Specifically,
firing rate was calculated over 1-min intervals before administra-
tion of drugs and during the drug effect; peak drug-induced
changes in firing rate were expressed as the percentage change
from the control firing rate according to the formula [(FRD-
FRC)/FRC] X 100, where FRD is the firing rate during the peak
drug effect and FRC is the control firing rate. Thus, the change in
firing rate is expressed as a percentage of the initial firing rate,
which controls for small changes in firing rate, which may occur
over time.
All EPSCs were recorded at a holding potential (Vh) of
270 mV. Physiological identification of DA neurons was based
on the presence of hyperpolarizing current (Ih), which was
greater than 60 pA during a step from 250 to 2100 mV, and
the rate of spontaneous action potential activity (1–5 Hz) with
spike widths $1.2 ms [21,26,27]. To evoke monosynaptic
excitatory postsynaptic currents (eEPSCs), a bipolar stainless
steel-stimulating electrode was placed 50–200 mm away from the
recorded VTA neuron. Electrical stimuli (100–200 ms in dura-
tion) were applied at the rate of 0.05–0.1 Hz. Near the start of
the recording, an input/output curve was obtained, and the
stimulation was then set to 20–30% of the maximum, an
intensity that evoked stable responses with no failures. Paired
eEPSCs were elicited with a pair of identical stimuli separated by
an interval of 50 ms. Series resistance was checked before and
after the experiments by series resistance compensation. To
measure input resistance, we applied a 5 mV, 400 ms hyperpo-
larizing pulse and divided 5 mV by the final value of the evoked
current. The data would be discarded if series resistance (15–
30 MV) or input resistance (300–500 MV) changed by more
than 20% during the whole-cell recording.
Data analysis
Spontaneous discharges and excitatory postsynaptic currents
(EPSCs) were counted and analyzed with Clampfit 9.2 (Molec-
ular Devices Co). Spontaneous or miniature EPSCs (sEPSCs and
mEPSCs) were screened automatically (8 pA amplitude thresh-
old), checked visually, and accepted or rejected according to their
rise (,1.5 ms) and decay (,3.5 ms) times. The height of evoked
eEPSCs (eEPSCs) was measured with Clampfit 9.2 and was used
to calculate the paired pulse ratio (PPR = EPSC2/EPSC1),
where EPSC1 and EPSC2 were evoked by the first and second
stimuli at an interval of 50 ms. The eEPSC amplitude, PPR, and
the frequency of sEPSCs and mEPSCs during and after drug
applications were normalized to their mean value during the
initial control period (.3 min). These data were used to depict
summarized time courses (10–30 s per/bin). The baseline mean
values were obtained during the initial control period and the
mean values were obtained during drug application over a 2–
3 min period at the peak of a drug response. Drug effects were
expressed as % change (mean 6 SEM) from a pre-drug control
baseline. Paired or unpaired two-tailed t-test evaluated the
statistical significance of various drug effects (% change from
control baseline). Cumulative probability plots of the incidence of
various inter-event intervals and amplitudes (for 50–1000 sEPSCs
and mEPSCs), were recorded in control conditions and during
drug applications to the same neuron, were analyzed with the
Kolmogorov-Smirnov (K–S) test. In the figures, single eEPSCs or
paired eEPSCs are averages of .10 successive traces. Values of
p,0.05 were considered significant.
Chemicals and Applications
1-Methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline hydro-
bromide (Salsolinol), bicuculline, DL-2-amino-5-phosphono-vale-
ric acid (DL-APV), 6, 7-dinitroquinoxaline-2, 3-dione (DNQX),
QX-314, tetrodotoxin (TTX) were obtained from Sigma-Aldrich
Chemical Company (St Louis, MO, USA). (6)-SKF 83566 was
from TOCRIS Bioscience (Ellisville, MO, USA). The 10006stock
solutions were aliquoted and then stored at 220, 4uC, or room
temperature according to the catalog recommendations. APV
(50 mM) and DNQX (20 mM) were dissolved in ,0.1 N NaOH
and other agents in deionized water. Drugs at final concentration
were added to the superfusate.
Results
Salsolinol-induced increase in the firing rate of p-VTA DA
neurons is substantially attenuated by antagonists of
Gluergic NMDA and AMPA receptors
Whole-cell recording was performed in p-VTA-DA neurons in
coronal midbrain slices of rats. We chose p-VTA because a
previous in vivo study found that salsolinol has an effect on the
posterior but not anterior VTA [8]. DA neurons were identified by
Salsolinol Facilitates Glutamate Transmission
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our many published documents [21,23,28]. Most DA neurons
fired spontaneously in a regular pacemaker mode. As the basal
firing rate varied, each neuron served as its own control. We
recorded spontaneous firing for 5–10 min in the absence of
salsolinol and then switched the perfusion to a solution containing
salsolinol for 5–10 min before returning to control solution.
Recently, we have shown that salsolinol (0.01–1 mM) dose-
dependently increases the firing of DA neurons with a peak effect
at 0.1 mM [10]. In keeping with this, salsolinol (0.1 mM) robustly
increased the ongoing discharges recorded from current clamped
DA neurons (by 100.3615.6%, from 0.8860.17 to
1.8760.50 Hz, n=7, P,0.001, by paired t test; Fig. 1A). This
effect was reversible upon washout of salsolinol. An identical effect
of salsolinol was observed using the loose-patch cell-attached
configuration (data not shown).
Excitatory synaptic input mediated by glutamate is a key
component in the regulation of DA cell excitability [15]. To assess
whether salsolinol-induced excitation of DA neurons involves
activation of Gluergic ionotropic receptors, we compared
salsolinol’s effects in the absence and presence of the mixture of
APV (50 mM) and DNQX (20 mM), the antagonists of NMDA and
AMPA receptors. APV+DNQX slightly but significantly reduced
the firing rate of DA neurons to 80.066.4% of control (from
1.960.4 to 1.660.5 Hz, n=11, P=0.011; Fig. 1C). This indicates
a significant Gluergic influence which tonically facilitates DA cells’
activity. After the response to APV+DNQX stabilized, the
addition of salsolinol (0.1 mM) increased the firing by 33.567.4
% (n=6) (Fig. 1B). This increase was significant (P,0.05. vs. in the
absence of salsolinol), but was substantially smaller than
100.3615.6% that induced by salsolinol (0.1 mM) alone (Fig. 1D,
P,0.05, student’s unpaired t test). These data indicate that
salsolinol-induced stimulation of DA neurons is mediated, at least
partly, by Gluergic activity.
Salsolinol increases the frequency but not the amplitude
of spontaneous EPSCs (sEPSCs) in putative DA Neurons
We then examined if salsolinol would affect Gluergic transmis-
sion onto DA neurons. We recorded sEPSCs in the presence of
10 mM bicuculline at a holding potential (Vh) of 270 mV. Their
suppression by 20 mM DNQX (not shown) indicated that they
were indeed Gluergic events mediated by AMPA receptors.
Salsolinol (0.1 mM) increased their frequency by 50.9612.4%
(from 3.761.3 to 5.661.8 per 10 s, n=7, P=0.006, by paired t-
test, Fig. 2A). This is further shown in Fig. 2B by the sharp
increase in the probability of shorter intervals between successive
sEPSCs (Kolmogorov-Smirnov, K–S test, P,0.01). After washout
of salsolinol, sEPSC frequency returned to control levels (Fig. 2A).
Conversely, salsolinol (0.1 mM) did not alter sEPSC amplitudes
(control, 23.662.3 pA; salsolinol, 24.860.7 pA, n=7, p=0.53,
paired t-test). The cumulative probability plot of amplitudes
between successive sEPSCs also confirms this finding (K–S test,
P.0.5, Fig. 2C). It is generally believed that a significant effect on
sEPSC frequency without a concomitant effect on their amplitude
is good evidence for an interference with the release mechanisms.
Tetrodotoxin (TTX) abolishes Salsolinol’s increases of
spontaneous EPSCs in DA Neurons
To further characterize the effects of salsolinol on the
spontaneous EPSCs, we recorded miniature EPSCs (mEPSCs) in
the presence of bicuculline (10 mM) and TTX (0.5 mM), which
blocks action potential-generated events. TTX (0.5 mM) lowered
the frequency of spontaneous EPSCs to 33.466.0% of control
(from 2.760.7 to 0.860.4 per 10 s, n=3, P=0.008, paired t-test)
without altering their amplitude (97.061.3% of control, from
15.363.1 to 14.963.1 pA, n=3, p=0.14, paired t-test). In the
presence of TTX (0.5 mM), salsolinol (0.1 mM) did not significantly
altered either the mEPSC frequency (by 16.7615.5%, from
0.860.1 to 1.060.2 per 10 s, n=6, P=0.33, paired t-test), or their
amplitude (by 1.264.0%, control, 20.761.3 pA; salsolinol,
20.961.5 pA, n=6, P=0.9, paired t-test; Fig.3A–C). Thus,
salsolinol’s enhancement of Gluergic transmission is dependent
on TTX-sensitive Na
+ channels.
Figure 1. Salsolinol-induced stimulation of dopaminergic (DA)
neurons is attenuated by APV and DNQX. A1, Traces illustrate
spike discharge at the times indicated in A2. A2, Time course of the
increase in the ongoing pacemaking firing rate, recorded from a
current-clamped DA neuron in the posterior ventral tegmental area (p-
VTA) of a rat, by 0.1 mM salsolinol. B1, Traces obtained at the times
indicated in B2. B2, Time course of the effect of salsolinol on the firing
rate of a DA neuron in the presence of APV (50 mM) and DNQX (20 mM),
the antagonists of NMDA and AMPA receptors. C, Summary plot of
decease in firing rate by APV + DNQX. D, Summary plot (means 6
S.E.M.) of increase in firing rate of p-VTA DA neurons induced by
salsolinol (0.1 mM) in ACSF is larger than that in the APV+DNQX.
Numbers in bars indicate numbers of neurons tested. *P,0.05,
**P,0.01, paired t-test for salsolinol vs. pre-salsolinol control. Unpaired
t-test for salsolinol vs. APV+DNQX+salsolinol.
doi:10.1371/journal.pone.0036716.g001
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neurons
The above data indicate that salsolinol increases Gluergic
transmission via a presynaptic mechanism. To confirm this, we
tested the effect of salsolinol on EPSCs evoked by pairs of stimuli
(at 50 ms interval) applied by a local stimulating electrode in the
presence of 10 mM bicuculline and at a Vh of –70 mV. These
EPSCs were completely blocked by 20 mM DNQX (not shown),
indicating that they were mediated by AMPA receptors. Salsolinol
(0.1 mM) enhanced the amplitude of the first eEPSC (EPSC1,b y
34.862.5%, n=11; P,0.01, by paired t-test, Fig. 4A–C), but not
the second eEPSC (EPSC2) and thus decreased the paired-pulse
ratio (PPR=EPSC2/EPSC1, by 23.263.4% from 1.0860.05 to
0.8760.03; n=11, P,0.05, paired t-test, Fig. 4A and C). It’s well
documented that changes in transmitter release generally affect the
PPR [29,30].
Salsolinol-induced increase in EPSCs is abolished by a
D1Rs antagonist, SKF 83566
In the VTA, D1Rs are expressed on Gluergic axons [31] but not
on the soma of DA neurons [31,32]. The activation of D1Rs
increases glutamate levels in the VTA [20] as well as Gluergic
transmission in the globus pallidus [33]. As was recently shown by
ourlabthatethanol-inducedenhancementofGluergictransmission
onto VTA DA neurons involves D1Rs localized on the Gluergic
terminals [21,22], we wonder if salsolinol-induced enhancement of
Gluergic transmission onto VTA DA neurons also involves D1Rs.
WecomparedtheeffectsofsalsolinoloneEPSCsintheabsenceand
presence of SKF83566 (10 mM). As depicted in Fig. 5A–C, in the
presence of SKF83566, salsolinol (0.1 mM) failed to change either
eEPSC1 amplitude (by 26.7611.3%, n=9, P=0.6, paired t-test),
or the PPR (by 18.462.8% of control, from 1.0760.04 to
1.2560.08; n=9, P=0.2, paired t-test). These results indicated
that D1Rs are essential for salsolinol’s enhancement of Gluergic
transmission.
Salsolinol-induced excitation of VTA DA neurons is
attenuated by SKF 83566
To further assess the contribution of D1Rs to salsolinol’s
stimulation of DA neurons, we compared the effect of salsolinol on
the ongoing discharges of p-VTA DA neurons in the absence and
presence of SKF83566. In the presence of 10 mM SKF83566,
salsolinol (0.1 mM) significantly increased the firing rate, but only
Figure 2. Salsolinol increases frequency of spontaneous EPSCs
(sEPSCs) recorded from p-VTA DA neurons. EPSCs were recorded
in the presence of bicuculline (10 mM) at a holding potential of
270 mV. A1, Traces obtained at the times indicated in A2. A2, Time
course of 0.1 mM salsolinol-induced enhancement of sEPSC frequency in
one experiment. B, C, Cumulative probability plots of data from the
same cell show effects of salsolinol (0.1 mM) on sEPSC frequency (B) and
amplitudes (C). Insets: mean data (6 S.E.M., from seven neurons).
*P,0.05, **P,0.01, paired t-test for salsolinol vs. pre-salsolinol control.
doi:10.1371/journal.pone.0036716.g002
Figure 3. Tetrodotoxin (TTX) abolishes Salsolinol’s increase of
sEPSCs. The miniature EPSCs (mEPSCs) were recorded in p-VTA DA
neurons at a holding potential of 270 mV, in the presence of
bicuculline (10 mM) and TTX (0.5 mM). A1, Traces obtained at the times
indicated in A2. (A2) Time course of salsolinol-induced changes of
mEPSC frequency in one experiment. B, C, Cumulative probability plots
of inter-event intervals between mEPSCs (B) and their amplitudes (C).
Insets: mean data (6 S.E.M., from six neurons) confirm the absence of
significant effect of salsolinol (0.1 mM) on the frequency and the
amplitude of mEPSCs. *P,0.05, paired t-test for salsolinol vs. pre-
salsolinol control.
doi:10.1371/journal.pone.0036716.g003
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Fig. 6A–B), which is .50% smaller (Fig. 6C, P,0.05, by unpaired
t test) than 100.3%, the increase induced by 0.1 mM salsolinol
alone.
Discussion
We show here the first electrophysiological evidence of salsolinol
facilitation of Gluergic transmission onto p-VTA DA neurons in
acute midbrain slices. Salsolinol (0.1 mM) robustly increased the
spontaneous firing rate of DA neurons, which was substantially
attenuated by APV and DNQX. Furthermore, salsolinol signifi-
cantly increased the frequency of sEPSCs and the amplitude of the
first eEPSCs, but reduced the paired-pulse ratio of eEPSCs. The
effects of salsolinol on EPSCs were eliminated by the D1R
antagonist SKF83566. Finally, SKF83566 attenuated salsolinol-
induced increase in firing rate of p-VTA DA neurons. Taken
together, these data indicate that salsolinol, via the activation of
presynaptic D1Rs and consequently facilitation of Gluergic
transmission contributes substantially to salsolinol-induced excita-
tion of p-VTA DA neurons. Hence, salsolinol’s effect on DA
neurons involves activation of Gluergic transmission, in addition to
the suppression of GABAergic transmission [10].
Gluergic transmission is involved in Salsolinol-induced
excitation of VTA DA neurons
Recently we have shown that salsolinol (0.01–1 mM) stimulated
p-VTA DA neurons in brain slices of rats [10]. In this study, we
showed that salsolinol’s stimulation was substantially attenuated by
APV and DNQX. This finding clearly points to the involvement of
Gluergic transmission in salsolinol’s action.
It is well accepted that VTA DA neurons are important for the
response to reinforcement and reward signals. Accumulating
evidence suggests that the input and output elements of DA
neurons are essential components in the reward pathways.
Gluergic transmission plays an important role in the effects of
ethanol [34,35]. In several brain regions, ethanol inhibits NMDA
and non-NMDA glutamate receptors, as well as glutamate release
[36]. However, there are also reports that ethanol increases
glutamate release under some circumstances. Systemic adminis-
tration of ethanol increases glutamate release in the nucleus
accumbens of low-alcohol sensitive rats [37] and addiction-prone
Lewis rats [38]. Studies on the central nucleus of the amygdale
reveal that acute ethanol increases glutamate release only in rats
receiving chronic ethanol treatment [39,40]. We have previously
Figure 4. Salsolinol increases amplitude and decreases paired-
pulse ratio (PPR) of evoked EPSCs (eEPSCs) recorded from p-
VTA DA neurons. eEPSCs were recorded in the presence of
bicuculline (10 mM) at a holding potential of 270 mV. A, Salsolinol
(0.1 mM) sharply increased the peak amplitude of eEPSC1 and had
minimal effect on that of eEPSC2 evoked by paired stimulation (at 50-
ms interval) within the VTA, and hence reduced the PPR (EPSC2/EPSC1).
B, Time course of salsolinol-induced enhancement of eEPSC1 amplitude
in one experiment. C, Summary of salsolinol-induced changes (%) in
eEPSC1 amplitude and PPR (Mean 6 SEM, from eleven neurons).
*P,0.05, **P,0.01, paired t-test for salsolinol vs. pre-salsolinol control.
doi:10.1371/journal.pone.0036716.g004
Figure 5. The D1R antagonist SKF 83566 eliminates salsolinol’s
augmentation of eEPSCs. A, Current traces show that salsolinol did
not change the amplitude of eEPSC1 and PPR in the presence of 10 mM
SKF 83566. B, Time course of salsolinol-induced changes of eEPSC1
amplitude in nine experiments. C, Summary of salsolinol-induced
changes (%) in eEPSC1 amplitude and PPR in the presence of SKF 83566
(data from nine cells). *P,0.05, **P,0.01, paired t-test for salsolinol
application vs. pre-salsolinol control.
doi:10.1371/journal.pone.0036716.g005
Salsolinol Facilitates Glutamate Transmission
PLoS ONE | www.plosone.org 5 May 2012 | Volume 7 | Issue 5 | e36716demonstrated that ethanol enhanced Gluergic transmission to
VTA DA neurons [21,22]. In this study, we found salsolinol
enhanced Gluergic transmission onto DA neurons. The applica-
tion of APV+DNQX substantially attenuated salsolinol-induced
increase in the firing rate of DA neurons, indicating that Gluergic
activity contributes considerably to salsolinol-induced excitation of
DA neurons. Moreover, TTX abolished the increase in the
frequency of spontaneous EPSC induced by salsolinol, indicating
that salsolinol’s effect was dependent on TTX-sensitive Na
+
channels. Salsolinol did not alter the amplitude of both sEPSCs
and mEPSCs, indicating that salsolinol acted on the presynaptic
site. The presynaptic loci were further supported by salsolinol’s
effects on evoked EPSCs: it enhanced the amplitude of the first
EPSCs in response to the first stimuli of the paired stimuli but
decreased their paired-pulse ratio.
Role of D1Rs in salsolinol-induced excitation of VTA DA
neurons
DA receptors consist of D1-like (D1 and D5 receptors) and D2-
like (D2,D 3 and D4 receptors) families. Both D1R and the D2R
family (D2R in particular) [41] have been implicated in the
mechanisms of drug dependence and abuse. Disruption of D1R
gene expression [42] or administration of D1R antagonist [43]
attenuates or prevents alcohol-seeking behavior. D1Rs are
expressed on Gluergic axons [31] but not on the soma of VTA
DA neurons [31,32]. The activation of D1Rs increases glutamate
levels in the VTA [20] as well as Gluergic transmission in the
globus pallidus [33]. Previous works in our lab showed that
ethanol may enhance glutamate release by potentiation of D1R
function [21,22]. In this study, we found that SKF83566 abolished
salsolinol’s enhancement of the eEPSCs, indicating that this
enhancement is mediated by D1Rs. Salsolinol may increase the
somatodendritic release of dopamine, which may retrogradely
activate the D1Rs on the glutamate-releasing terminals, which in
turn increases glutamate release and the excitability of DA
neurons. Somatodendritic release of dopamine in the midbrain
dopamine neurons is Na
+ channel-dependent (see [44] for review).
In keeping with this, we found that the increase in the frequency of
spontaneous EPSCs was abolished by TTX. Interestingly,
salsolinol is more potent than ethanol in enhancing Gluergic
transmission as well as in excitation of DA neurons. The effective
concentration of salsolinol in enhancing Gluergic transmission is
much smaller than that of ethanol (peak effect: salsolinol: 0.1 mM
vs ethanol: 40 mM [21,22]. This is consistent with both in vivo
and in vitro findings that DA system is highly sensitive to salsolinol
[8,9,10]. We previously showed that ethanol-induced increase in
the release of glutamate (EPSCs) in the VTA was eliminated when
dopamine was depleted by the pretreatment of reserpine. Since
salsolinol is the condensation product of dopamine and acetalde-
hyde, the metabolic product of ethanol, depletion of dopamine
may prevent the formation of salsolinol. On the basis of the results
of this study, we propose that the observation that ethanol failed to
increase Gluergic transmission when dopamine was depleted may
well be explained by the lack of salsolinol formation.
VTA DA neurons receive numerous inputs which in turn can
modulate their eventual outputs. Integration of synaptic inputs and
intrinsic properties sets the frequency and pattern of firing
[45,46,47]. In this study, APV and DNQX, as well as SKF
83566, significantly attenuated but not totally abolished salsolinol-
induced increase in the firing rate of VTA DA neurons. This is in
line with our recent finding that salsolinol stimulates DA neurons
partly through activation of m opioid receptors, which leads to the
inhibition of GABAergic transmission onto VTA DA neurons. It is
worth noting that even in the presence of a mixture containing
APV+DNQX+gabazine, salsolinol could still significantly increase
the firing rate of p-VTA DA neurons (by 27.365.6%, n=10,
P=0.03) (G Xie and JH Ye, unpublished observation). Further-
more, since the sum of the reductions induced by gabazine and by
APV+DNQX in salsolinol-induced increase in firing rate of DA
neurons is larger than one, the effects of salsolinol on GABAergic
and Gluergic pathways may not be paralleled. This observation
indicates the complex nature of salsolinol’s effects. Other
mechanisms underlying salsolinol-induced excitation of VTA DA
neurons remain to be fully unveiled. On the bases of the findings of
this study and our recent report [10], we propose that both
Gluergic and GABAergic transmissions play essential roles in
salsolinol-induced stimulation of VTA DA neurons. Our present
work offers new insights into salsolinol’s central mechanism under
its rewarding properties.
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Figure 6. SKF83566 attenuates salsolinol-induced excitation of
p-VTA DA neurons. A, Ongoing firing in the presence of SKF83566
(10 mM), recorded from a current-clamped p-VTA DA neuron, was
increased by salsolinol (0.1 mM). B, Pooled data show that in the
presence of SKF83566, salsolinol induced an increase in firing rate of p-
VTA DA neurons from thirteen cells. C, Summary (means 6 S.E.M.) of
the effects of salsolinol (0.1 mM) on DA neuron firing rate in the absence
(ACSF) and presence of SKF 83566 (SKF 63566). Numbers of cells are
indicated in the brackets. *P,0.05 by un-paired t-test, salsolinol vs. SKF
83566+salsolinol.
doi:10.1371/journal.pone.0036716.g006
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